Evaluation of Potential In Vitro Recombination Events in Codon Deoptimized FMDV Strains

Codon deoptimization (CD) has been recently used as a possible strategy to derive foot-and-mouth disease (FMD) live-attenuated vaccine (LAV) candidates containing DIVA markers. However, reversion to virulence, or loss of DIVA, from possible recombination with wild-type (WT) strains has yet to be analyzed. An in vitro assay was developed to quantitate the levels of recombination between WT and a prospective A24-P2P3 partially deoptimized LAV candidate. By using two genetically engineered non-infectious RNA templates, we demonstrate that recombination can occur within non-deoptimized viral genomic regions (i.e., 3′end of P3 region). The sequencing of single plaque recombinants revealed a variety of genome compositions, including full-length WT sequences at the consensus level and deoptimized sequences at the sub-consensus/consensus level within the 3′end of the P3 region. Notably, after further passage, two recombinants that contained deoptimized sequences evolved to WT. Overall, recombinants featuring large stretches of CD or DIVA markers were less fit than WT viruses. Our results indicate that the developed assay is a powerful tool to evaluate the recombination of FMDV genomes in vitro and should contribute to the improved design of FMDV codon deoptimized LAV candidates.

[1]  G. Medina,et al.  Foot-and-Mouth Disease Virus Interserotypic Recombination in Superinfected Carrier Cattle , 2022, Pathogens.

[2]  K. VanderWaal,et al.  Viral Population Diversity during Co-Infection of Foot-And-Mouth Disease Virus Serotypes SAT1 and SAT2 in African Buffalo in Kenya , 2022, Viruses.

[3]  E. Rieder,et al.  Simultaneous and Staggered Foot-and-Mouth Disease Virus Coinfection of Cattle , 2021, Journal of virology.

[4]  Paolo Ribeca,et al.  Mutagenesis Mapping of RNA Structures within the Foot-and-Mouth Disease Virus Genome Reveals Functional Elements Localized in the Polymerase (3Dpol)-Encoding Region , 2021, mSphere.

[5]  E. Wimmer,et al.  Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy , 2021, Proceedings of the National Academy of Sciences.

[6]  P. Bieniasz,et al.  Mechanisms of Attenuation by Genetic Recoding of Viruses , 2021, mBio.

[7]  D. H. Dung,et al.  Novel Recombinant Foot-and-Mouth Disease Virus Circulating in Vietnam , 2021, Microbiology Resource Announcements.

[8]  S. Mueller,et al.  Use of Synonymous Deoptimization to Derive Modified Live Attenuated Strains of Foot and Mouth Disease Virus , 2021, Frontiers in Microbiology.

[9]  Paolo Ribeca,et al.  Correction: Pervasive within-host recombination and epistasis as major determinants of the molecular evolution of the foot-and-mouth disease virus capsid , 2020, PLoS pathogens.

[10]  M. Landthaler,et al.  Mechanism of Virus Attenuation by Codon Pair Deoptimization. , 2020, Cell reports.

[11]  P. Collins,et al.  Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding , 2019, Front. Immunol..

[12]  Andrés Perez,et al.  Phylogeographical and cross‐species transmission dynamics of SAT1 and SAT2 foot‐and‐mouth disease virus in Eastern Africa , 2019, Molecular ecology.

[13]  O. Peersen,et al.  Picornavirus RNA Recombination Counteracts Error Catastrophe , 2019, Journal of Virology.

[14]  C. Cameron,et al.  Senecavirus-Specific Recombination Assays Reveal the Intimate Link between Polymerase Fidelity and RNA Recombination , 2019, Journal of Virology.

[15]  A. El-Sayed,et al.  Foot-and-mouth disease vaccines: recent updates and future perspectives , 2019, Archives of Virology.

[16]  A. Bosch,et al.  Hepatitis A Virus Codon Usage: Implications for Translation Kinetics and Capsid Folding. , 2018, Cold Spring Harbor perspectives in medicine.

[17]  Patrick T. Dolan,et al.  Mechanisms and Concepts in RNA Virus Population Dynamics and Evolution. , 2018, Annual review of virology.

[18]  David J. Evans,et al.  Mechanisms and consequences of positive-strand RNA virus recombination. , 2018, The Journal of general virology.

[19]  Paolo Ribeca,et al.  Within-Host Recombination in the Foot-and-Mouth Disease Virus Genome , 2018, Viruses.

[20]  D. H. Dung,et al.  A traditional evolutionary history of foot-and-mouth disease viruses in Southeast Asia challenged by analyses of non-structural protein coding sequences , 2018, Scientific Reports.

[21]  C. Wright,et al.  Full Genome Sequencing Reveals New Southern African Territories Genotypes Bringing Us Closer to Understanding True Variability of Foot-and-Mouth Disease Virus in Africa , 2018, Viruses.

[22]  Dusan Kunec,et al.  Attenuation of Viruses by Large-Scale Recoding of their Genomes: the Selection Is Always Biased , 2018, Current Clinical Microbiology Reports.

[23]  Grace Campagnola,et al.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity , 2017, Journal of Virology.

[24]  P. Jesudhasan,et al.  Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies , 2017, mBio.

[25]  O. Peersen,et al.  Poliovirus Polymerase Leu420 Facilitates RNA Recombination and Ribavirin Resistance , 2016, Journal of Virology.

[26]  G. Medina,et al.  Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response , 2015, Journal of Virology.

[27]  P. Minor.  Live attenuated vaccines: Historical successes and current challenges. , 2015, Virology.

[28]  J. Bull,et al.  Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it? , 2015, Virus evolution.

[29]  J. Rushton,et al.  The economic impacts of foot and mouth disease – What are they, how big are they and where do they occur? , 2013, Preventive veterinary medicine.

[30]  T. Boulinier,et al.  Contacts and foot and mouth disease transmission from wild to domestic bovines in Africa , 2013 .

[31]  M. Larocco,et al.  A Continuous Bovine Kidney Cell Line Constitutively Expressing Bovine αVβ6 Integrin Has Increased Susceptibility to Foot-and-Mouth Disease Virus , 2013, Journal of Clinical Microbiology.

[32]  J. Hollister,et al.  A Safe Foot-and-Mouth Disease Vaccine Platform with Two Negative Markers for Differentiating Infected from Vaccinated Animals , 2012, Journal of Virology.

[33]  T. de los Santos,et al.  Inoculation of Swine with Foot-and-Mouth Disease SAP-Mutant Virus Induces Early Protection against Disease , 2011, Journal of Virology.

[34]  N. Juleff,et al.  The pathogenesis of foot-and-mouth disease I: viral pathways in cattle. , 2011, Transboundary and emerging diseases.

[35]  E. Holmes,et al.  Why do RNA viruses recombine? , 2011, Nature Reviews Microbiology.

[36]  Steven Skiena,et al.  Live Attenuated Influenza Vaccines by Computer-Aided Rational Design , 2010, Nature Biotechnology.

[37]  K. Crandall,et al.  The evolution of foot-and-mouth disease virus: impacts of recombination and selection. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[38]  A. Bosch,et al.  Codon usage and replicative strategies of hepatitis A virus. , 2007, Virus research.

[39]  E. Domingo,et al.  The structure of a protein primer–polymerase complex in the initiation of genome replication , 2006, The EMBO journal.

[40]  B. Baxt,et al.  Analysis of a Foot-and-Mouth Disease Virus Type A24 Isolate Containing an SGD Receptor Recognition Site In Vitro and Its Pathogenesis in Cattle , 2005, Journal of Virology.

[41]  D. Rock,et al.  Comparative Genomics of Foot-and-Mouth Disease Virus , 2005, Journal of Virology.

[42]  E. Domingo,et al.  A segmented form of foot-and-mouth disease virus interferes with standard virus: a link between interference and competitive fitness. , 2005, Virology.

[43]  P. Gailiunas,et al.  Relationship of foot-and-mouth disease virus plaque size on cell cultures to infectivity for cattle by intramuscular inoculation , 1966, Archiv für die gesamte Virusforschung.

[44]  U. Desselberger,et al.  Crossover regions in foot-and-mouth disease virus (FMDV) recombinants correspond to regions of high local secondary structure , 2005, Archives of Virology.

[45]  J. Mackenzie.  Virulence of temperature-sensitive mutants of foot-and-mouth disease virus , 2005, Archives of Virology.

[46]  B. Baxt,et al.  Foot-and-Mouth Disease , 2004, Clinical Microbiology Reviews.

[47]  P. Mason,et al.  Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. , 1997, Virology.

[48]  P. Mason,et al.  The foot-and-mouth disease virus leader proteinase gene is not required for viral replication , 1995, Journal of virology.

[49]  K. Kirkegaard,et al.  The mechanism of RNA recombination in poliovirus , 1986, Cell.

[50]  J. Mackenzie,et al.  Evidence for recombination between two different immunological types of foot-and-mouth disease virus. , 1975, The Australian journal of experimental biology and medical science.

[51]  J. Mackenzie,et al.  Temperature-sensitive mutants of foot-and-mouth disease virus: the isolation of mutants and observations on their properties and genetic recombination. , 1975, The Journal of general virology.

[52]  C. Pringle,et al.  The origin of hybrid variants derived from subtype strains of foot-and-mouth disease virus. , 1968, The Journal of general virology.

[53]  C. Pringle.  Recombination between conditional lethal mutants within a strain of foot-and-mouth disease virus. , 1968, The Journal of general virology.

[54]  C. Pringle.  EVIDENCE OF GENETIC RECOMBINATION IN FOOT-AND-MOUTH DISEASE VIRUS. , 1965, Virology.